We identified four plasma proteins with robust genetic evidence supporting their roles in AML pathogenesis: TNFAIP8, TCL1A, and WFDC1 as risk factors, and TNFSF8 as a protective factor. This evidence concerns the gene TNFSF8 and acute myeloid leukemia.